Erythromycin: A Microbial and Clinical Perspective After 30 Years of Clinical Use (First of Two Parts)
- 1 March 1985
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 60 (3) , 189-203
- https://doi.org/10.1016/s0025-6196(12)60219-5
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- In vitro activity of seventeen antimicrobial agents againstGardnerella vaginalisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1982
- Gram-Negative Anaerobic Bacilli: Their Role in Infection and Patterns of Susceptibility to Antimicrobial Agents. II. Little-Known Fusobacterium Species and Miscellaneous GeneraClinical Infectious Diseases, 1981
- The Macrophage as an Effector CellNew England Journal of Medicine, 1980
- The Pulmonary-Alveolar MacrophageNew England Journal of Medicine, 1979
- Emergence of Multiply Resistant PneumococciNew England Journal of Medicine, 1978
- Sensitivity of Rothia dentocariosaJournal of Antimicrobial Chemotherapy, 1978
- Streptococcus pneumoniae resistant to erythromycin and clindamycinThe Journal of Pediatrics, 1978
- Penetration of Penicillin into Human Phagocytes Containing Neisseria gonorrhoeae: Intracellular Survival and Growth at Optimum Concentrations of AntibioticJournal of General Microbiology, 1976
- Hemophilus influenzae type B susceptibility to 17 antibioticsThe Journal of Pediatrics, 1975
- THE PROTECTION OF PATHOGENIC MICROORGANISMS BY LIVING TISSUE CELLSThe Journal of Experimental Medicine, 1916